Category : Pharmaceuticals


Purdue Pharma opioid settlement nears final approval

OxyContin maker Purdue Pharma and Sackler family close to finalising landmark opioid settlement worth up to $7 billion after overwhelming support from claimants. Historic deal could end years of litigation.

Sandy Roberts' Cancer Treatment Now on PBS

Australian TV legend Sandy Roberts receives life-changing news as his costly myeloma treatment is added to the PBS, slashing costs for thousands of patients across the country.

WeightWatchers to Sell Wegovy Weight-Loss Pill

WeightWatchers announces plans to sell Novo Nordisk's Wegovy in pill form, a strategic move following its bankruptcy. Discover how this impacts the competitive weight-loss drug market.

New Malaria Drug Shows 97% Cure Rate

Scientists unveil a revolutionary malaria treatment with a 97% cure rate, potentially the biggest advance in decades. Learn how this could transform global health.

FDA removes 'black box' warnings from HRT

US FDA removes severe 'black box' warnings from menopause hormone therapy, a move hailed as a return to evidence-based women's healthcare. Discover the implications.

Trump slams 'fat shot' weight loss drugs in explosive rant

Donald Trump launches astonishing attack on revolutionary weight-loss injections like Wegovy and Ozempic, branding them the 'fat shot' while claiming natural methods are superior. The former president's controversial health comments spark medical debate.

Trump's plan to slash weight-loss drug prices

Former President Donald Trump proposes dramatic government intervention to cut costs of blockbuster drugs like Ozempic and Wegovy, challenging pharmaceutical giants and reshaping US healthcare policy.

Trump pledges to cut weight-loss drug prices

Former President Donald Trump vows to dramatically reduce prices of GLP-1 medications including Ozempic and Wegovy if re-elected, targeting pharmaceutical giants in latest healthcare pledge.

NHS patients may get only generic drugs, warns AstraZeneca

The CEO of pharmaceutical giant AstraZeneca warns that NHS patients may be limited to generic medicines unless the health service increases what it pays for branded drugs, raising concerns about access to cutting-edge treatments.

Page 12 of 20
Pickt mobile sticky banner — logo, tagline and CTA button